106
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Primary cutaneous anaplastic CD30+ large-cell lymphoma that completely regressed after incisional skin biopsy

, , , , &
Pages 163-166 | Received 02 Sep 2010, Accepted 21 Oct 2010, Published online: 18 Nov 2010

References

  • Bekkenk, M.W., Geelen, F.A., van Voorst Vader, P.C., Heule, F., Geerts, M.L., van Vloten, W.A., Meijer, C.J., Willemze, R. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000, 95, 3653–3661.
  • Kempf, W., Sander, C.A. Classification of cutaneous lymphomas—an update. Histopathology 2010, 56, 57–70.
  • Beljaards, R.C., Kaudewitz, P., Berti, E., Gianotti, R., Neumann, C., Rosso, R., Paulli, M., Meijer, C.J., Willemze, R. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 1993, 71, 2097–2104.
  • Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerroni, L., Chimenti, S., Diaz-Peréz, J.L., Geerts, M.L., Goos, M., Knobler, R., Ralfkiaer, E., Santucci, M., Smith, N., Wechsler, J., van Vloten, W.A., Meijer, C.J. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997, 90, 354–371.
  • Willemze, R., Meijer, C.J. Primary cutaneous CD30-positive lymphoproliferative disorders. Hematol. Oncol. Clin. North Am. 2003, 17, 1319–1332, vii.
  • Lott, D.G., Akst, L.M., Greene, D., Roberts, J.K. T-cell primary cutaneous anaplastic large cell lymphoma mimicking appearance of large basal cell carcinoma. Otolaryngol. Head. Neck Surg. 2006, 135, 170–171.
  • Shehan, J.M., Kalaaji, A.N., Markovic, S.N., Ahmed, I. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. J. Am. Acad. Dermatol. 2004, 51, 103–110.
  • Mori, M., Manuelli, C., Pimpinelli, N., Mavilia, C., Maggi, E., Santucci, M., Bianchi, B., Cappugi, P., Giannotti, B., Kadin, M.E. CD30–CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression. Blood 1999, 94, 3077–3083.
  • Levi, E., Wang, Z., Petrogiannis-Haliotis, T., Pfeifer, W.M., Kempf, W., Drews, R., Kadin, M.E. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression. J. Invest. Dermatol. 2000, 115, 1034–1040.
  • Clarke, L.E., Bayerl, M.G., Bruggeman, R.D., Mauger, D., Ioffreda, M.D., Abou-Elella, A., Helm, K.F. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin. Am. J. Surg. Pathol. 2005, 29, 452–459.
  • Skiljevic, D., Nikolic, M.M., Milinkovic, M., Bonaci-Nikolic, B. Regressing anaplastic CD30-positive large-cell lymphoma of the skin. Acta Dermatovenerol. Alp. Panonica. Adriat. 2006, 15, 131–134.
  • Smith, C.A., Gruss, H.J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. CD30 antigen, a marker for Hodgkin’s lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993, 73, 1349–1360.
  • Keun, Y.K., Woodruff, R., Sangueza, O. Response of CD30+ large cell lymphoma of skin to bexarotene. Leuk. Lymphoma 2002, 43, 1153–1154.
  • Didona, B., Benucci, R., Amerio, P., Canzona, F., Rienzo, O., Cavalieri, R. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). Br. J. Dermatol. 2004, 150, 1198–1201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.